AIM ImmunoTech Inc. (AMEX: AIM) open the trading on March 04, 2021, with a bit cautious approach as it glided -7.52% to $2.09. During the day, the stock rose to $2.25 and sunk to $2.00 before settling in for the price of $2.26 at the close. Taking a more long-term approach, AIM posted a 52-week range of $1.60-$7.11.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -6.60%. Meanwhile, its Annual Earning per share during the time was 44.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 73.20%. This publicly-traded company’s shares outstanding now amounts to $40.69 million, simultaneously with a float of $40.22 million. The organization now has a market capitalization sitting at $88.41 million. At the time of writing, stock’s 50-day Moving Average stood at $2.22, while the 200-day Moving Average is $2.29.
It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 31 employees. It has generated 5,385 per worker during the last fiscal year. Meanwhile, its income per employee was -366,654. The stock had 0.15 Receivables turnover and 0.00 Total Asset turnover. For the Profitability, stocks gross margin was -537.86, operating margin was -8831.43 and Pretax Margin of -6809.29.
AIM ImmunoTech Inc. (AIM) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. AIM ImmunoTech Inc.’s current insider ownership accounts for 0.50%, in contrast to 7.60% institutional ownership. According to the most recent insider trade that took place on Feb 25, this organization’s Director bought 10,638 shares at the rate of 2.35, making the entire transaction reach 24,999 in total value, affecting insider ownership by 92,538. Preceding that transaction, on Feb 24, Company’s CEO & President bought 11,062 for 2.26, making the whole transaction’s value amount to 25,000. This particular insider is now the holder of 209,630 in total.
AIM ImmunoTech Inc. (AIM) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 9/29/2020 suggests? It has posted -$0.08 earnings per share (EPS) beating the forecaster’s viewpoint (set at -$0.08) by $0. This company achieved a net margin of -6809.29 while generating a return on equity of -105.45. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
AIM ImmunoTech Inc.’s EPS increase for this current 12-month fiscal period is 73.20% and is forecasted to reach -0.35 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 25.00% through the next 5 years, which can be compared against the 44.30% growth it accomplished over the previous five years trading on the market.
AIM ImmunoTech Inc. (AMEX: AIM) Trading Performance Indicators
Let’s observe the current performance indicators for AIM ImmunoTech Inc. (AIM). It’s Quick Ratio in the last reported quarter now stands at 50.00. The Stock has managed to achieve an average true range (ATR) of 0.21. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 442.03.
In the same vein, AIM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.44, a figure that is expected to reach -0.07 in the next quarter, and analysts are predicting that it will be -0.35 at the market close of one year from today.
Technical Analysis of AIM ImmunoTech Inc. (AIM)
[AIM ImmunoTech Inc., AIM] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 27.26% While, its Average True Range was 0.21.
Raw Stochastic average of AIM ImmunoTech Inc. (AIM) in the period of the previous 100 days is set at 31.21%, which indicates a major rise in contrast to 9.68% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 60.24% that was lower than 83.35% volatility it exhibited in the past 100-days period.